Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]PM-PBB3 PET in Young Onset Dementia
NCT04248270Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of florzolotau in Dementia, sponsored by Chang Gung Memorial Hospital. Primary endpoints: Proportion of subtype in Young Onset Dementia at 3 years, Mean tau deposition in different region of interest from subtype of YOD at 3 years and 1 more. Status: unknown.
02
Drugs
florzolotau
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT04248270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04248270.